Siemens Healthcare has announced that the Food and Drug Administration (FDA) recently cleared the company’s CAIPIRINHA (Controlled Aliasing in Volumetric Parallel Imaging Results IN Higher Acceleration) software as part of Siemens’ syngo MR D13A software package for parallel magnetic resonance (MR) imaging. The software helps enable patients with breath-holding difficulties to reduce the amount of time they hold their breath by up to 50 percent without sacrificing imaging resolution or contrast.

Siemens’ CAIPIRINHA software enables acquisition of higher-quality 3-D volumetric interpolated breath-hold sequence (VIBE) T1 images through higher acceleration factors. CAIPIRINHA software will be included as standard with Siemens’ D13A software for MAGNETOM Aera 1.5 Tesla and MAGNETOM Skyra 3T MRI systems; it will be available with Siemens’ B19 software as an upgrade for Siemens’ MAGNETOM Avanto 1.5T and MAGNETOM Verio 3T systems.